The Onco'Zine Brief

In this edition of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Leonard Farber, MD, a board-certified Radiation Oncologist, and healthcare executive. Farber is recognized for his ability to identify ground-breaking technologies and position them for success in clinical practice. He recently joined EHMET Health, an emerging medical device company with a state-of-the-art device for providing...

In this edition of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Dr. William R. Stern, M.D., a board-certified gastroenterologist and Fellow of the American College of Gastroenterology, at the Capital Digestive Care group outside of Washington, DC, about advancements in colorectal cancer screening. Also joining us today is Sue Spielberg, a patient of the Capital Digestive Care group. At the...

In this edition of The Onco’Zine Brief, Peter Hofland, Ph. D., talk with Ajay Nooka, MD, MPH, FACP, Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, and Suzanne Trudel, MSc, MD, Associate Professor in the Department of Medicine at the University of Toronto and an Attending Physician at Princess Margaret Cancer Centre. Hofla...

In this episode of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Malte Peters, MD, Chief Research and Development Officer at MorphoSys, and Peter Langmuir, MD., Vice President, Oncology Drug Development at Incyte. In our program today, which was originally recorded in August 2020, Hofland, Peters, and Langmuir also talk about the companies and the transformative therapies they have develope...

In this episode of The Onco’Zine Brief Peter Hofland talks with Richard Schilsky, M.D. Dr. Schilsky, the Chief Medical Officer and Executive Vice President of the American Society of Clinical Oncology (ASCO), is an oncologist who specializes in new drug development and treatment of gastrointestinal cancers. His impressive experience and many accomplishments in both clinical medicine and clinical r...

In this episode of The Onco’Zine Brief Peter Hofland talks with Pascal Touchon, President, Chief Executive Officer, and member of the Board of Directors Atara Biotherapeutics. With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon has committed his career to transform the lives of patients with serious medical conditions. Before joining Atara Biotherapeutics Dr....

In this edition of The Onco’Zine Brief Peter Hofland talks with Peter Keeling about Personalized Medicine, diagnostic testing, and the effect of Covid-19 on cancer and cancer diagnostics. Hofland and Keeling also talk about the world’s first Diagnostic Network for Precision Medicine. Peter Keeling is the chief executive officer and Founder of Diaceutics. Since its founding, the company has built t...

In this episode of The Onco’Zine Brief Peter Hofland Ph. D., talks with Raj Malik M.D. and Robert Epstein M.D. Malik is Chief Medical Officer and Senior Vice President, R&D, at G1 Therapeutics. He leads the company’s clinical development, medical affairs, regulatory affairs, biometrics, translational medicine and preclinical teams. Epstein is an epidemiologist with extensive expertise in pharmaco-...

In this episode of The Onco’Zine Brief Peter Hofland talks with Peggy Berry, Vice president of Global Regulatory Affairs at Rakuten Medical.* Rakuten Medical is developing a technology platform called Illuminox™ which is based on a cancer therapy called Near Infrared Photoimmunotherapy. This technology was originally developed by Hisataka Kobayashi, M.D., Ph. D. and his team at the National Cancer...

In this episode of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Anthony Yanni, M.D., Senior Vice President, patient-centricity at Astellas. In this role, Yanni is responsible for leading the development and execution of Astellas’ global patient-centricity strategy. To understand patient centricity, consider the fact that 10 years ago, patient-centricity wasn’t even a concept – In most case...

In this episode of The Onco’Zine Brief Peter Hofland, Ph. D., talks with Tim Blauwkamp, Ph. D., Chief Scientific Officer and co-founder of Karius. Karius, based in Redwood City, CA, has developed a non-invasive liquid biopsy, a blood test, called the Karius Test®. The test is based on next-generation sequencing of microbial cell-free DNA and can rapidly detect pathogens causing serious infections,...

In this edition of The Onco’Zine Brief, Peter Hofland, Ph. D., talks with Vince McRuiz and Margo Shoup, MD, FACS. Margo Shoup is a nationally recognized surgical oncologist who specializes in gastrointestinal cancers and sarcomas. She is also the senior vice president, and system chair of the Nuvance Health Cancer Institute, where she provides strategic and clinical leadership for all aspects of N...

In this edition of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Armon Sharei, Ph. D. Chief Executive Officer of SQZ Biotech, about the development and manufacturing of cell therapies. Traditionally, the foundation of cancer treatment included surgery, chemotherapy, and radiation therapy. But over the last few decades, targeted therapies —drugs that specifically target molecular changes see...

In this edition of The Onco’Zine Brief Peter Hofland, Ph. D. talks with Christian Massacesi, MD, Senior Vice President, Head of Late Development Oncology R&D at AstraZeneca and with Jeffrey Skolnik, MD, Vice President, Clinical Development at Inovio Pharmaceuticals about new data and exciting developments both companies are presenting during the 2020 virtual annual meeting of the American Society...

In this edition of The Onco’Zine Brief, Peter Hofland talking with Helen Sabzevari, the president of Precigen. Precigen is a biopharmaceutical company dedicated to the discovery and clinical-stage development of the next generation of gene and cell therapies using precision technology. The company is developing novel therapeutic agents that are designed to target the most urgent and difficult dise...

In this episode of The Onco'Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland and Sperber talk about sacituzumab govitecan, a novel antibody-drug conjugate. At the time of the interview, the drug was not yet approved, but in the weeks following the interview, the U.S. Food and Drug Administration (FDA) approved sacituzumab govitecan (Trodel...

Struggling in the heat and humidity of the summer of 2016, Terri Conneran believed that her asthma was uncontrolled. In August that year, her physician assistant prescribed her a preventive inhaler. That autumn brought the excuse of allergies, plus time for the new inhaler to take effect. By Christmas 2016, nasal congestion, and a heavy feeling chest with shortness of breath it was time to again s...

In this episode The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS) held December 10 – 14, 2019 in San Antonio, Texas, Peter Hofland talks with Susan Rafte, a 25+ year survivor of metastatic breast cancer and patient advocate. In 1994, eight and a half months after birth to her daughter Marika, Susan Rafte, only 30 years old, was diagnosed with stage III ducta...

In this edition of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS), held December 10 - 14, 2019 in San Antonio, Texas, Peter Hofland talks with leading breast cancer experts, and patients about metastatic breast cancer and health related quality of life hrQoL issues including sexual intimacy, bone health and joint pain. In this roundtable, panelists will a...

In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben & Catherine Ivy Foundation. The Ben & Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma (GBM) - research in the world. To date, the Ivy Foundation has funded clinical trials and basic science in...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Muhammed Murtaza and Dr. Thomas Slavin about liquid biopsies Murtaza is Assistant Professor and co-Director of the Center for Noninvasive Diagnostics at TGen in Phoenix, AZ, and Dr. Slavin is Assistant Clinical Professor, Departments of Medical Oncology & Therapeutics Research and Population Sciences, Division of Clinical Cancer G...

Today in The Onco’Zine Brief Peter Hofland talks with Dr. Michael Caligiuri, President of City of Hope National Medical Center in Los Angeles, California and Deana and Steve Campbell Physician-in-Chief Distinguished Chair, and Dr. Jianhua Yu, professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, and a Scholar of The Leukemia & Lymphoma Society. By combinin...

Today in The Onco’Zine Brief Peter Hofland talks with Diane Zipursky Quale. Together with her late husband John Quale, Diane, who holds a BA from Stanford University and a JD from the National Law Center, George Washington University, is Co-Founder and Director of the Bladder Cancer Advocacy Network (BCAN), the only national advocacy organization devoted to advancing bladder cancer research and su...

In this edition of The Onco’Zine Brief Peter Hofland talks with Laura Panos Smith, a certified genetic counselor and vice president of commercial operations at Ambry Genetics. Ms. Smith leads a large team responsible for the implementation of key strategic initiatives for Ambry Genetics. This includes the daily support and education for patients and healthcare providers, as well as marketing and s...

In this edition of The Onco’Zine Brief Peter Hofland talks with Holly LaDuca, a certified genetic counselor and manager of clinical Research oncology at Ambry Genetics. Identifying an individual’s genetic information is nothing new. And while, over the last decades, most people have become familiar with genetic ancestry testing, or genetic genealogy, as a way for people interested in their family...